Prudential Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q4
Sell
-4,511
Closed -$684K 2767
2022
Q3
$684K Sell
4,511
-895
-17% -$136K ﹤0.01% 1928
2022
Q2
$788K Sell
5,406
-174
-3% -$25.4K ﹤0.01% 1915
2022
Q1
$662K Buy
5,580
+1,122
+25% +$133K ﹤0.01% 2070
2021
Q4
$660K Sell
4,458
-13,353
-75% -$1.98M ﹤0.01% 2093
2021
Q3
$2.47M Buy
17,811
+13,315
+296% +$1.85M ﹤0.01% 1345
2021
Q2
$437K Buy
4,496
+350
+8% +$34K ﹤0.01% 2179
2021
Q1
$283K Buy
4,146
+77
+2% +$5.26K ﹤0.01% 2294
2020
Q4
$349K Buy
4,069
+56
+1% +$4.8K ﹤0.01% 2201
2020
Q3
$261K Buy
4,013
+879
+28% +$57.2K ﹤0.01% 2212
2020
Q2
$229K Buy
+3,134
New +$229K ﹤0.01% 2207
2019
Q4
Sell
-24,188
Closed -$1.01M 2539
2019
Q3
$1.01M Sell
24,188
-59,029
-71% -$2.46M ﹤0.01% 1853
2019
Q2
$3.65M Buy
+83,217
New +$3.65M 0.01% 1299